University Medical Center Groningen in the Netherlands is launching a major initiative to address long-standing gaps in women’s health care, calling the current state of medical research and treatment “no longer explainable.” The push comes as researchers and clinicians highlight persistent disparities in how women’s conditions are studied, diagnosed, and treated compared to men.
Key Findings
- A new research focus will prioritize women-specific health challenges, including reproductive health, chronic pain, and conditions often overlooked in clinical trials.
- Health officials say the existing medical system fails to account for biological differences between sexes, leading to misdiagnoses and delayed treatments.
- The initiative will include expanded funding for studies on women’s health and training programs to improve clinician awareness of sex-specific medicine.
Why This Matters
Women’s health has long been a blind spot in medical research. A 2022 study published in The BMJ found that only 40% of clinical trials include women as participants, and fewer than 20% analyze data by sex. This gap contributes to disparities in treatment outcomes: for example, women are 50% more likely to be misdiagnosed with heart disease than men, according to the European Society of Cardiology.
The new initiative at UMCG aims to bridge these gaps by embedding women’s health into core research and clinical practice. “We can no longer justify ignoring the differences between male and female bodies in medicine,” said a spokesperson for the center. “The consequences are too severe for patients.”
How the Initiative Will Work
UMCG’s approach includes three main strategies:
- Research prioritization: A dedicated funding stream will support studies on conditions where sex differences are critical, such as autoimmune diseases, pelvic pain, and menopause-related disorders.
- Clinician training: Medical students and practicing physicians will receive updated education on sex-specific symptoms and treatments, with a focus on areas where women are frequently overlooked.
- Public awareness: Campaigns will target patients and providers to highlight when women’s symptoms may be dismissed or misattributed, such as in cases of chronic pain or mental health conditions.
One of the most urgent targets is the underdiagnosis of conditions like endometriosis, where women wait an average of seven years for a proper diagnosis, according to the World Endometriosis Research Foundation. UMCG’s initiative will also examine why women’s pain is often undertreated, a phenomenon documented in multiple studies.
Reactions from the Medical Community
Health advocates have welcomed the move but say broader systemic change is needed. “This is a step forward, but it’s not enough to rely on a single institution,” said a representative from the Dutch Women’s Health Coalition. “Policy makers must ensure these principles are adopted nationwide.”
Critics also note that similar initiatives in other countries, such as the U.S. National Institutes of Health’s 2016 policy requiring sex-specific analysis in trials, have faced slow implementation. UMCG’s leaders acknowledge the challenge but emphasize that their center will track progress closely.
What’s Next
The initiative is set to launch in early 2025, with the first funded research projects expected to begin by mid-year. UMCG will collaborate with other European medical centers to share findings and standardize approaches. Long-term goals include influencing national health guidelines to reflect sex-specific medicine.
For now, the center is calling on other institutions to follow suit. “The time for excuses is over,” said a senior researcher involved in the planning. “Women’s health cannot be an afterthought.”
